Other News To Note

 Bionomics Ltd., of Adelaide, Australia, presented new data on BNC375, its drug candidate with potential for the treatment of memory loss in Alzheimer's disease, at the 33rd Annual Meeting of the Australian Neuroscience Society in Melbourne, Australia.